Summary
Metachromatic leukodystrophy is a lysosomal storage disorder caused by the deficiency of arylsulphatase A (EC 3.1.6.1). This results in the intralysosomal storage of cerebroside sulphate, which leads to a progressive demyelination of the nervous system. The patients usually die within a few years from the onset of symptoms. Clinically, there are different forms of the disease and the molecular basis for this heterogeneity is unknown. The gene for arylsulphatase A has recently been cloned and provides a necessary tool for the exact description of the molecular defects occurring in the different forms of metachromatic leukodystrophy. Metachromatic leukodystrophy can also be caused by the deficiency of an arylsulphatase A activator protein (sphingolipid activator protein B). The cDNA for the precursor of this protein has been isolated and a mutant cDNA of one patient has been analysed. A substantial arylsulphatase A deficiency can also occur in healthy individuals, a phenotype termed pseudodeficiency. Two concurrent mutations have been identified in this low arylsulphatase A activity allele. This permitted the development of a rapid assay which allows the detection of the pseudodeficiency allele. Bone marrow transplantation has been tried in several metachromatic leukodystrophy patients and there is evidence that this treatment might slow or even halt the progression of the disease. A final conclusion as to whether bone marrow transplantation is a suitable therapy for metachromatic leukodystrophy cannot be drawn yet.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Austin, J. Metachromatic sulfatides in cerebral white matter and kidney. Proc. Soc. Exp. Biol. Med. 100 (1959) 361
Austin, J. H., Balasubramanian, A. S., Patabiramen, T. N., Saraswathi, S., Basu, D. K.and Bachhawat, B. K. A controlled study of enzymatic activities in three human disorders of glycolipid metabolism. J. Neurochem. 10 (1963) 805
Bach, G. and Neufeld, E. F. Synthesis and maturation of cross reactive glycoprotein in fibroblasts deficient in arylsulfatase A activity. Biochem. Biophys. Res. Commun. 112 (1983) 198–205
Baldinger, S., Pierpont, M. E. and Wenger, D. A. Pseudodeficiency of arylsulfatase A: a counselling dilemma. Clin. Genet. 31 (1987) 70–76
Bayerer, E., Ladisch, S., Philippart, M., Brill, N., Nuwer, M., Sparkes, R. S. and Feig, S. A. Bone marrow transplantation for metachromatic leukodystrophy. Lancet. 1 (1985) 471–473
Dewji, N. N., Wenger, D. A., Fujibayashi, S., Donoviel, M., Esch, F., Hill, F. and O’Brien, J. S. Molecular cloning of the sphingolipid activator protein-1 (SAP 1). The sulfatide sulfatase activator. Biochem. Biophys. Res. Commun. 134 (1986) 989–994
Dewji, N. N., Wenger, D. A. and O’Brien, J. S. Nucleotide sequence of cloned cDNA for human sphingolipid activator protein precursor. Proc. Natl. Acad. Sci. USA. 84 (1987) 8652–8656
Dubois, G., Harzer, K. and Baumann, N. Very low arylsulfatase A and cerebroside sulfatase activities in leukocytes of healthy members of a metachromatic leukodystrophy family. Am. J. Hum. Genet. 29 (1977) 191–194
Fischer, G. and Jatzkewitz, H. The activator of cerebroside sulphatase. Binding studies with enzyme and substrate demonstrating the detergent function of the activator protein. Biochim. Biophys. Acta. 481 (1977) 561–572
Fluharty, A. L., Meek, W. E. and Kihara, H. Pseudoarylsulfatase A deficiency: evidence for a structurally altered enzyme. Biochem. Biophys. Res. Commun. 112 (1983) 191–197
Fujibayashi, S. and Wenger, D. A. Biosynthesis of the sulfatide/Gm I activator protein (SAP-1) in control and mutant cultured skin fibroblasts. Biochim. Biophys. Acta. 875 (1986) 554–562
Fürst, W., Machleidt, W. and Sandhoff, K. The precursor of sulfatide activator protein is processed to three different proteins. Biol. Chem. Hoppe-Seyler. 369 (1988) 317–328
Gieselmann, V., Polten, A., Kreysing, J. and von Figura, K. Arylsulfatase pseudodeficiency: Loss of a polyadenylation signal and N-glycosylation site. Proc. Natl. Acad. Sci. USA. 86 (1989) 9436–9440
Gustayson, K. H. and Hagberg, B. The incidence and genetics of MLD in Northern Sweden. Acta Pediatr. Scand. 60 (1971) 585–590
Herz, B. and Bach, G. Arylsulfatase A in pseudodeficiency. Hum. Genet. 661 (1984) 147–150
Hohenschutz, C., Friedl, W., Schlör, K. H., Waheed, A., Conzelmann, E., Sandhoff, K. and Propping, P. Probable metachromatic leukodystrophy/pseudodeficiency compound heterozygote at an arylsulfatase A locus with neurologic and psychiatric symptomatology. Am. J. Med. Genet. 31 (1988) 169–175
Hohenschutz, C., Eich, P., Friedl, W., Waheed, A., Conzelmann, E. and Propping, P. Pseudodeficiency of arylsulfatase A: a common genetic polymorphism with possible disease implications. Hum. Genet. 82 (1989) 45–48
Hoogerbrugge, P. M., Suzuki, K., Suzuki, K. et al. Donor derived cells in the central nervous system of twitcher mice after bone marrow transplantation. Science. 239 (1988a) 1035–1038
Hoogerbrugge, P. M., Poorthuis, B. J., Romme, A. E., van de Kamp, J. J., Wagemaker, G. and von Bekkum, D. W. Effect of bone marrow transplantation on enzyme levels and clinical course in the neurologically affected twitcher mouse. J. Clin. Invest. 81 (1988b) 1790–1794
Jatzkewitz, H. Zwei Typen von Cerebrosidschwefelsäureestern als sog. Prälipoide und Speichersubstanzen bei der metachromatischen Leukodystrophie. Z. Physiol. Chem. 311 (1958) 279
Kihara, H., Chen-Kung, H., Fluharty, A. L., Tsay, K. K., Hartlage, P. L. Prenatal diagnosis of metachromatic leukodystrophy in a family with pseudodarylsulfatase A deficiency by the cerebroside sulfate loading test. Pediatr. Res. 14 (1980) 224–227
Kolodny, E. H., Moser, H. W. Sulfatide lipidosis: metachromatic leukodystrophy. In Stanbury, J. B., Wyngaarden, J. B., Fredrickson, D. S., Goldstein, J. L. and Brown, M. S. (eds.) The Metabolic Basis of Inherited Diseases. McGraw-Hill, New York, 1983, pp. 881–905
Kretz, K., Ginns, E., Carson, G., Morimoto, S., Kishimoto, Y., Fluharty, A. L. and O’Brien, J. S. Characterization of a mutation in a family with saposin B deficiency. Am. Soc. Hum. Genet. (1989) abstract
Kreysing, J., von Figura, K. and Gieselmann, V. The structure of the human arylsulfatase A gene. ESGLD Meeting (1989). Ittingen, abstract
Krivit, W., Lipton, M. E., Lockman, L. A., Tsai, M., Dyck, P. J., Smith, S., Ramsay, N. K. C. and Kersey, J. Prevention of deterioration in metachromatic leukodystrophy by bone marrow transplantation. Am. J. Med. Sci. 294 (1987) 80–85
Li, S. C., Sonnino, S., Tettamanti. G. and Li, Y. T. Characterization of a non-specific activator protein for the enzymatic hydrolysis of glycolipids. J. Biol. Chem. 263 (1988) 6588–6591
Mehl, E. and Jatzkewitz, H. Evidence for the genetic block in metachromatic leukodystrophy. Biochem. Biophys. Res. Commun. 19 (1965) 407
Morimoto, S., Martin, B. M., Kishimoto, Y. and O’Brien, J. S. Saposin D: A sphingomyelinase activator. Biochem. Biophys. Res. Commun. 156 (1988) 403–410
Morimoto, S., Martin, B. M., Yamamoto, Y., Kretz, K. A., O’Brien, J. S. and Kishimoto, Y. Saposin A: Second cerebrosidase activator protein. Proc. Natl. Acad. Sci. USA. 86 (1989) 3389–3393
Nakano, T., Sandhoff, K., Stümper, J., Christomanou, H. and Suzuki, K. Structure of full length cDNA coding for sulfatide activator, a co-(f-glucosidase and two other homologous proteins: Two alternate forms of the sulfatide activator. J. Biochem. Tokyo. 105 (1989) 152–154
O’Brien, J. S., Kretz, K. A., Dewji, N. N., Wenger, D. A., Esch, F. and Fluharty, A. L. Coding of two sphingolipid activator proteins (SAP 1 and SAP 2) by the same genetic locus. Science. 234 (1988) 1098–1101
Peiffer, J. Ăśber die metachromatischen Leukodystrophien (Typ Scholz). Arch. Psychiatr. Nerrenkr. 199 (1959) 386
Porter, N. T., Fluharty, A. L. and Kihara, H. Correction of abnormal cerebroside sulfate metabolism in cultured metachromatic leukodystrophy fibroblasts. Science. 172 (1971) 1263–1265
Scholz, W. Klinische, pathologisch anatomische und erbbiologische Untersuchungen bei familiärer diffuser Hirnsklerose im Kindesalter. Z. Gesamte Neurol. Psychiatr. 99 (1925) 42
Shapiro, L. J., Aleck, K. A., Kaback, M. M., Itabashi, H., Desnick, R. J., Brand, N., Stevens, R. L., Fluharty, R. L. and Kihara, H. Metachromatic leukodystrophy without arylsulfatase A deficiency. Pediatr. Res. 13 (1979)
Stein, C., Gieselmann, V., Kreysing, J., Schmidt, B., Pohlmann, R., Waheed, A., Meyer, E. H., O’Brien, J. S. and von Figura, K. Cloning and expression of human arylsulfatase A. J. Biol. Chem. 264 (1989) 1252–1259
Taylor, R. M., Farrow, B. R., Stewart, G. J., Healy, P. J. Enzyme replacement in nervous tissue after allogeneic bone marrow transplantation for fucosidosis in dogs. Lancet. 1 (1986) 772–774
Tonnesen, T., Vrang, C., Wiesmann, U., Christomanou, H. and Lou, H. O. Atypical metachromatic leukodystrophy? Hum. Genet. 67 (1984) 170–173
Waheed, A., Hasilik, A. and von Figura, K. Synthesis and processing of arylsulfatase A in human skin fibroblasts. Hoppe-Seyler’s Z. Physiol. Chem. 363 (1982) 425–430
Waheed, A., Steckel, F., Hasilik, A. and von Figura, K. Two allelic forms of human arylsulfatase A with different numbers of asparagine linked oligosaccharides. Am. J. Hum. Genet. 35 (1983) 228–233
Wenger, D. A., De Gala, G., Williams, C., Taylor, H. A., Stevenson, R. E., Pruitt, J. R., Miller, J., Garen, P. D. and Balentine, J. D. Clinical pathological and biochemical studies on an infantile case of sulfatide/GMI activator protein deficiency. Am. J. Med. Genet. 33 (1989) 255–265
Yeager, A. M., Brennan, S., Tiffany, C., Moser, H. W. and Santos, W. G. Prolonged survival and remyelination after hematopoietic cell transplantation in the twitcher mouse. Science. 225 (1984) 1052–1054
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1990 SSIEM and Kluwer Academic Publishers
About this chapter
Cite this chapter
Gieselmann, V., von Figura, K. (1990). Advances in the Molecular Genetics of Metachromatic Leukodystrophy. In: Harkness, R.A., Pollitt, R.J., Addison, G.M. (eds) Carbohydrate and Glycoprotein Metabolism; Maternal Phenylketonuria. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-2175-7_17
Download citation
DOI: https://doi.org/10.1007/978-94-009-2175-7_17
Publisher Name: Springer, Dordrecht
Print ISBN: 978-0-7923-8947-7
Online ISBN: 978-94-009-2175-7
eBook Packages: Springer Book Archive